NXTM Share Price

Open 29.57 Change Price %
High 29.99 1 Day -0.14 -0.47
Low 29.12 1 Week 0.95 3.34
Close 29.36 1 Month 3.34 12.84
Volume 310967 1 Year 15.23 107.78
52 Week High 29.99
52 Week Low 13.49
NXTM Important Levels
Resistance 2 30.17
Resistance 1 29.83
Pivot 29.49
Support 1 28.89
Support 2 28.55
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
CSCO 33.74 0.42%
More..
NASDAQ USA Top Gainers Stocks
MOSY 3.50 54.19%
LOCM 0.09 50.00%
LMIA 13.66 48.64%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
IFON 0.75 25.00%
PPHM 0.55 25.00%
GSIT 6.99 22.20%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

NxStage Medical, Inc. (NASDAQ: NXTM)

NXTM Technical Analysis 5
As on 17th Feb 2017 NXTM Share Price closed @ 29.36 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 22.40 & Strong Buy for SHORT-TERM with Stoploss of 26.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
NXTM Target for February
1st Target up-side 28.71
2nd Target up-side 29.98
3rd Target up-side 31.25
1st Target down-side 25.09
2nd Target down-side 23.82
3rd Target down-side 22.55
NXTM Other Details
Segment EQ
Market Capital 626582144.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nxstage.com
NXTM Address
NXTM
350 Merrimack Street
Lawrence, MA 01843
United States
Phone: 978-687-4700
NXTM Latest News
Interactive Technical Analysis Chart NxStage Medical, Inc. ( NXTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NxStage Medical, Inc.
NXTM Business Profile
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company�s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market.